Colgate-Palmolive (NYSE:CL) Stock Rating Upgraded by Wells Fargo & Company

Colgate-Palmolive (NYSE:CLGet Rating) was upgraded by stock analysts at Wells Fargo & Company from an “underweight” rating to an “equal weight” rating in a research note issued to investors on Monday, Marketbeat reports. The firm presently has a $80.00 price target on the stock, up from their previous price target of $71.00. Wells Fargo & Company‘s price target points to a potential downside of 0.32% from the company’s previous close.

A number of other research analysts also recently commented on the stock. Raymond James initiated coverage on shares of Colgate-Palmolive in a research report on Thursday, April 7th. They issued a “market perform” rating for the company. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Colgate-Palmolive from $88.00 to $87.00 in a research report on Tuesday, July 19th. Atlantic Securities downgraded shares of Colgate-Palmolive from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $92.00 to $80.00 in a research report on Tuesday, May 3rd. Stifel Nicolaus cut their target price on shares of Colgate-Palmolive from $90.00 to $88.00 in a research note on Wednesday, April 13th. Finally, JPMorgan Chase & Co. cut their target price on shares of Colgate-Palmolive from $79.00 to $78.00 in a research note on Thursday, July 21st. Eleven research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $84.57.

Colgate-Palmolive Stock Down 1.0 %

Colgate-Palmolive stock opened at $80.26 on Monday. The company has a market cap of $67.25 billion, a P/E ratio of 34.74, a price-to-earnings-growth ratio of 5.67 and a beta of 0.48. Colgate-Palmolive has a 1-year low of $72.20 and a 1-year high of $85.61. The company has a fifty day simple moving average of $78.21 and a 200 day simple moving average of $78.34. The company has a current ratio of 1.18, a quick ratio of 0.72 and a debt-to-equity ratio of 14.31.

Colgate-Palmolive (NYSE:CLGet Rating) last released its earnings results on Friday, July 29th. The company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. The business had revenue of $4.48 billion during the quarter, compared to the consensus estimate of $4.35 billion. Colgate-Palmolive had a net margin of 10.98% and a return on equity of 315.10%. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.80 earnings per share. Research analysts anticipate that Colgate-Palmolive will post 3.02 earnings per share for the current fiscal year.

Insider Activity

In other news, insider John W. Kooyman sold 19,683 shares of the business’s stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $78.49, for a total value of $1,544,918.67. Following the completion of the transaction, the insider now directly owns 7,007 shares in the company, valued at approximately $549,979.43. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In related news, insider John W. Kooyman sold 19,683 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $78.49, for a total transaction of $1,544,918.67. Following the sale, the insider now directly owns 7,007 shares of the company’s stock, valued at approximately $549,979.43. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Philip G. Shotts sold 10,000 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $78.52, for a total transaction of $785,200.00. Following the sale, the vice president now directly owns 46,094 shares in the company, valued at $3,619,300.88. The disclosure for this sale can be found here. In the last ninety days, insiders sold 79,683 shares of company stock worth $6,297,119. 0.31% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Colgate-Palmolive

Institutional investors have recently added to or reduced their stakes in the business. TCI Wealth Advisors Inc. lifted its position in shares of Colgate-Palmolive by 76.0% in the 2nd quarter. TCI Wealth Advisors Inc. now owns 315 shares of the company’s stock worth $25,000 after purchasing an additional 136 shares during the period. Core Alternative Capital lifted its position in shares of Colgate-Palmolive by 924.3% during the 1st quarter. Core Alternative Capital now owns 379 shares of the company’s stock valued at $29,000 after acquiring an additional 342 shares during the period. Verity Asset Management Inc. acquired a new position in shares of Colgate-Palmolive during the 1st quarter valued at $29,000. Horan Securities Inc. acquired a new position in shares of Colgate-Palmolive during the 4th quarter valued at $30,000. Finally, Carl Stuart Investment Advisor Inc. acquired a new position in shares of Colgate-Palmolive during the 1st quarter valued at $30,000. 78.12% of the stock is owned by institutional investors.

Colgate-Palmolive Company Profile

(Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.